This month, the NSF released preliminary R&D spending numbers for the US federal government for fiscal year 2011 (FY11), ending September 30, 2011. The data suggest the substantial impact that the absence of American Recovery and Reinvestment Act of 2009 (ARRA) funding had on R&D spending in FY11 (see IBO 6/15/12) and general changes in […]
Higher investments in new product development and increased R&D personnel spending elevated R&D spending in 2011. Total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and lab product companies grew 14.2% to $1.96 billion, compared with 12.1% growth for the same companies in 2010 (see table, page 6). […]
Austin, TX 7/9/12—Luminex has definitely agreed to acquire molecular diagnostics firm GenturaDx for $50 million in cash, subject to working-capital reconciliation and potential contingent consideration. GenturaDx is in late-stage development of an integrated, automated, real-time PCR system that utilizes a single-use cassette. Luminex plans to integrate its MultiCode-RTx chemistry with the instrument and commercialize assays […]
Hilden, Germany and Germantown, MD 6/25/12—QIAGEN has announced the acquisition of next-generation sequencer (NGS) developer Intelligent Biosystems for an undisclosed amount. Further details of the acquisition were unavailable. QIAGEN disclosed the acquisition as part of a broader announcement of its entry into the NGS market. The company plans to launch a complete workflow for NGS, […]
According to recent figures from the NSF, funding from the American Recovery and Reinvestment Act 2009 (ARRA) (see IBO 2/28/09) contributed an additional $17.4 billion in constant fiscal 2005 dollars to federal obligations for R&D and R&D plant (facilities and fixed equipment) funding in fiscal year (FY) 2009 and FY10 combined. This accounted for 7% […]
The number of CROs in the US quadrupled from 2000 to 2011 to reach more than 3,100, according to Tufts Center for the Study of Drug Development (CSDD). Tufts CSDD examined 3,244 US CROs in 15 major geographic areas, which were thought to represent about three-quarters of US CROs. These firms had total 2011 revenues […]
London, UK 5/9/12—LGC Standards has acquired VHG Labs, a US-based supplier of spectrochemical standards, lab instrument consumables and product-testing services, for an undisclosed amount. “For LGC Standards, this latest acquisition builds on our strategy to increase our footprint in the US market,” said LGC Standards Managing Director David Richardson. “Importantly, it is also a good […]
London, UK 3/5/12—Abcam, a supplier of protein research tools, has agreed to acquire Epitomics for $155 million (net Epitomics’ $15 million in cash) in cash and stock. Epitomics provides rabbit monoclonal antibodies (RabMAbs) and has three units: Reagents, which develops and distributes antibodies for research applications; custom antibodies for research and diagnostic applications; and IVD […]
Carlsbad, CA 1/16/12—Life Technologies has agreed with DaAn Gene to form Life Technologies DaAn Diagnostics, a joint venture diagnostic business in China. DaAn Gene is a Chinese molecular in vitro diagnostic solutions provider. The joint venture will develop and commercialize molecular diagnostic assays using Life Technologies’ 3500 Dx capillary electrophoresis system and Big Dye Cycle […]
Academic and Government Spending Concerns In 2011, concerns about cuts to the NIH budget and European governments’ research spending kept instrument and lab product companies on edge, affecting sales growth and operations, especially at life science companies. Uncertainty about budget changes froze spending at some US labs, while cutbacks affected labs in certain European countries. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
